Cardiac Science Reports Q2 Revenue; Resumes AED...(--- ...),Health

Date:8/10/2009

--- Net cash provided by financing activities 502 173 --- --- Effect of exchange rate changes on cash and cash equivalents 79 - Net change in cash and cash equivalents 305 5,231 Cash and cash equivalents, beginning of period 37,563 22,490 Cash and cash equivalents, end of period $37,868 $27,721 ======= =======

                   Cardiac Science Corporation and Subsidiaries
             Condensed Consolidated Statements of Cash Flows (unaudited)
                                 (in thousands)

                                                        Six Months Ended
                                                            June 30,
                                                            --------
                                                         2009       2008
                                                         ----       ----

     Operating Activities:
            Net income (loss)                          $(2,303)    $4,511

            Adjustments to reconcile net income (loss)
             to net cash provided by operating
             activities:
                   Stock-based compensation              1,213      1,046
                   Depreciation and amortization         3,067      3,233
                   Deferred income taxes                (1,765)     2,462

                   Changes in operating assets and
                    liabilities, net of businesses
                    acquired:
                           Accounts receivable, net      8,717       (313)
                           Inventories 
'/>"/>
SOURCE  Cardiac Science Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 
Related medicine news :

1. Electronic Health Records Help Cardiac Patients Remain Healthy
2. Cooling treatment after cardiac arrest is cost-effective, Penn study shows
3. Harrison City ROCKS! Set for August 15, Music Festival to Benefit Cardiac Research at Childrens Hospital of Pittsburgh
4. Patriot Scientific Corporation Announces Cardiac Science Corporations Purchase of a Moore Microprocessor Patent(TM) Portfolio License
5. Many Heart Attack Patients Not Referred to Cardiac Rehab  
6. Worlds First Cardiac Adult Stem Cell Patient and Physicians Discuss Clinical Trial
7. Roche Cardiac 200 Offers Rapid Cardiac Diagnostics for the Point of Care
8. Need for At-Home Blood Pressure Monitoring Underscored by High-Profile Cardiac Deaths
9. Cardiac CT is more cost effective when managing low-risk patients with chest pain
10. Improving Care for Cardiac Patients is Centerpiece of American Society of Nuclear Cardiology Meeting
11. ERT Launches New Online Gateway to Improve Cardiac Safety in Clinical Trials